Re-Vana Therapeutics
Drug delivery company developing sustained-release therapeutics
Re-Vana Therapeutics has raised €11M across 1 funding round from 6 investors, most recently a Series A round in Nov 2022. Based in Belfast, UK; active in Healthtech. Data as of 28 Oct 2026.
Belfast, UKwww.revanatx.com ↗
Total raised
€11M
€11,468,774
Funding rounds
1
Investors
6
distinct backers
Active since
2022-11
latest 2022-11
Funding by year
EUR raised per yearRe-Vana Therapeutics — funding by year — interactive chart.
Data table
| Re-Vana Therapeutics — funding by year | |
|---|---|
| 2022 | €11M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-11-30 | Series A | €11M | Co-Fund NI,ExSight Ventures,QUBIS,Techstart Ventures,TwinFocus Capital Partners,Visionary Venture Fund | View deal → |
Investors
6Related news
- Re-Vana Therapeutics Raises USD11.9M in Series A Fundingfinsmes.com · 2022-12
Similar companies
same sector or countryGlobal coverage: FundingData